Medical News

RSS

First-of-its-kind platform generates antitumor immunity and improves responses to checkpoint inhibitors

Researchers at The University of Texas MD Anderson Cancer Center have developed an ultrasound-guided cancer immunotherapy platform that generates systemic antitumor immunity and improves the therapeutic efficacy of immune checkpoint blockade.

30 May 2022

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Breast cancer and type 2 diabetes would seem to be distinctly different diseases, with commonality only in their commonality.

30 May 2022

Study shows how stress has a major impact on the immune system's ability to fight infections

Acute stress can be detrimental to fighting off infection, especially COVID-19, and increases the chance of dying in mouse models.

30 May 2022

Exploring virological profiles of recently emerged SARS-CoV-2 Omicron variants

Researchers explored the virological profiles of novel SARS-CoV-2 Omicron variants.

30 May 2022

Topical ocular administration of progesterone could be viable treatment for retinitis pigmentosa

Retinitis pigmentosa is a degenerative disease affecting the photoreceptor cells in the retina, known as cones and rods.

30 May 2022

Researchers investigate COVID-19 mortality among introverts and extroverts

Researchers investigated the association between introversion and risk of mortality during the COVID-19 pandemic.

30 May 2022

Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

Researchers reported findings of a systematic antigenic analysis of the circulating SARS-CoV-2 Omicron subvariants such as BA.2.12.1, BA.4, and BA.5.

30 May 2022

Method for predicting neutralization and protection based on variant-specific antibody measurements to SARS-CoV-2 antigens

Researchers reported a method to predict neutralization and protection against SARS-CoV-2 antigens.

30 May 2022

Study evaluates waning levels of protection against SARS-CoV-2 infection among recovered persons and uninfected BNT162b2 vaccinees

Researchers assessed the characteristics of natural and hybrid immunity to SARS-CoV-2 infections.

30 May 2022

Direct comparison of immune memory responses to four COVID-19 vaccines

Researchers evaluated host immune responses to four COVID-19 vaccines representing three different vaccine technology platforms, focusing on immune memory responses.

30 May 2022

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

Researchers assessed the humoral immune responses generated by the third Pfizer-BioNTech BNT162b2 mRNA vaccination against SARS-CoV-2 among hemodialysis patients.

30 May 2022

Researchers evaluate atovaquone as a COVID-19 treatment

Researchers evaluated a drug, atovaquone, for COVID-19 treatment.

30 May 2022

Researchers report the case of a non-vaccinated patient coinfected with SARS-CoV-2 Omicron BA.1 and BA.2

A recent study published in The Lancet Microbe described the case of a non-vaccinated female coinfected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1 and BA.2 subvariants.

30 May 2022

Study finds high rates of hospital-based care for residents of retirement homes in Ontario

Residents of retirement homes in Ontario have high rates of hospital-based care compared to residents in long-term care (LTC) facilities and to people living in the community, found new research published in CMAJ.

30 May 2022

SARS-CoV-2 virus entered the United States one month before the official date, study reveals

Researchers from the Department of Applied Mathematics and the Ramón Margalef Multidisciplinary Institute for Environmental Research (IMEM) at the University of Alicante (UA) continue to make progress in the study of the spread of COVID-19.

30 May 2022

Excess deaths in Canada during COVID-19 pandemic vary widely by province, analysis shows

An analysis of excess deaths in Canada during the COVID-19 pandemic shows wide variation by province and underscores the need for better and consistent data for current and future health crisis management.

30 May 2022

Environmental pollutants may be the reason behind development of type 1 diabetes

The environmental pollutants we consume are probably the reason why some people develop type 1 diabetes. Even low concentrations of such pollutants can result in cells producing less insulin, reveals a new study from the University of Oslo.

30 May 2022

Investigating post-COVID complaints after Delta versus Omicron variant infections

A new study discusses whether infection with the SARS-CoV-2 Omicron variant increases the risk of post-COVID complaints Delta infection.

30 May 2022

Researchers investigate gestational diabetes mellitus and its association with maternal and fetal outcomes

Researchers quantify the outcomes of pregnancies complicated by gestational diabetes.

30 May 2022

Investigating incidence and clinical features of post-acute sequelae of COVID-19 in children and adolescents

Researchers identify symptoms and systematic conditions associated with PASC in children

30 May 2022

Medical News

First-of-its-kind platform generates antitumor immunity and improves responses to checkpoint inhibitors

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Study shows how stress has a major impact on the immune system's ability to fight infections

Exploring virological profiles of recently emerged SARS-CoV-2 Omicron variants

Topical ocular administration of progesterone could be viable treatment for retinitis pigmentosa

Researchers investigate COVID-19 mortality among introverts and extroverts

Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

Method for predicting neutralization and protection based on variant-specific antibody measurements to SARS-CoV-2 antigens

Study evaluates waning levels of protection against SARS-CoV-2 infection among recovered persons and uninfected BNT162b2 vaccinees

Direct comparison of immune memory responses to four COVID-19 vaccines

Hemodialysis patients obtain a robust humoral response from a third dose of the BNT162b2 vaccine, study finds

Researchers evaluate atovaquone as a COVID-19 treatment

Researchers report the case of a non-vaccinated patient coinfected with SARS-CoV-2 Omicron BA.1 and BA.2

Study finds high rates of hospital-based care for residents of retirement homes in Ontario

SARS-CoV-2 virus entered the United States one month before the official date, study reveals

Excess deaths in Canada during COVID-19 pandemic vary widely by province, analysis shows

Environmental pollutants may be the reason behind development of type 1 diabetes

Investigating post-COVID complaints after Delta versus Omicron variant infections

Researchers investigate gestational diabetes mellitus and its association with maternal and fetal outcomes

Investigating incidence and clinical features of post-acute sequelae of COVID-19 in children and adolescents

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News